![]() |
|
|
Vol. 62, Issue 2, 281-288, August 2002
Activity
Department of Biochemistry, The University of Texas Health Science
Center, San Antonio, Texas
The human B1 bradykinin (BK) receptor (B1R) is more efficacious than
the human B2 BK receptor (B2R) in both ligand-independent and
agonist-dependent coupling to Gq/11-mediated phospholipase C
activity. In fact, B1R is constitutively active, whereas B2R exhibits little if any constitutive activity. To evaluate the role of
the C-terminal domain in receptor Gq/11 coupling, we
constructed chimeric and C-terminally truncated receptors. The slopes
of the increase in basal and agonist-dependent cellular
phosphoinositide hydrolysis as a function of receptor density in
transiently transfected human embryonic kidney 293 cells provided
parameters of receptor coupling. Exchanging the C-terminal domains
between the two receptors revealed that these domains are largely
responsible for the difference in coupling. B1R truncation showed that
this receptor does not directly depend on the C-terminal domain for
efficient coupling, although coupling is dramatically augmented by
residues in the membrane-distal portion of the domain downstream from
Tyr327. On the other hand, coupling of B2R is absolutely
dependent on a membrane-proximal epitope in the C-terminal domain
upstream from Lys315. This epitope is adjacent to a basic
residue, Arg311, which exerts an inhibitory effect on
coupling. Arg311 is not conserved in B1R, and complementary
mutations in B2R and B1R showed that this residue, together with
previously identified serines and threonines, acts to attenuate the
coupling efficacy of B2R. Therefore, the C-terminal domain participates
intimately in the efficacy of B1R and B2R Gq/11 coupling by
contributing both positive and negative regulatory epitopes.
This article has been cited by other articles:
![]() |
C. Sanden, J. Enquist, S. H. Bengtson, H. Herwald, and L. M. F. Leeb-Lundberg Kinin B2 Receptor-Mediated Bradykinin Internalization and Metalloendopeptidase EP24.15-Dependent Intracellular Bradykinin Degradation J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 24 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. McCulloch, V. Morrow, S. Milasta, I. Comerford, G. Milligan, G. J. Graham, N. W. Isaacs, and R. J. B. Nibbs Multiple Roles for the C-terminal Tail of the Chemokine Scavenger D6 J. Biol. Chem., March 21, 2008; 283(12): 7972 - 7982. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Enquist, C. Skroder, J. L. Whistler, and L.M. F. Leeb-Lundberg Kinins Promote B2 Receptor Endocytosis and Delay Constitutive B1 Receptor Endocytosis Mol. Pharmacol., February 1, 2007; 71(2): 494 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Verzijl, L. Pardo, M. van Dijk, Y. K. Gruijthuijsen, A. Jongejan, H. Timmerman, J. Nicholas, M. Schwarz, P. M. Murphy, R. Leurs, et al. Helix 8 of the Viral Chemokine Receptor ORF74 Directs Chemokine Binding J. Biol. Chem., November 17, 2006; 281(46): 35327 - 35335. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kotarsky, A. Boketoft, J. Bristulf, N. E. Nilsson, A. Norberg, S. Hansson, C. Owman, R. Sillard, L. M. F. Leeb-Lundberg, and B. Olde Lysophosphatidic Acid Binds to and Activates GPR92, a G Protein-Coupled Receptor Highly Expressed in Gastrointestinal Lymphocytes J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 619 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. D. Santos, L. A. Gardner, S. W. White, and S. W. Bahouth Characterization of the Residues in Helix 8 of the Human beta1-Adrenergic Receptor That Are Involved in Coupling the Receptor to G Proteins J. Biol. Chem., May 5, 2006; 281(18): 12896 - 12907. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Kang, C. Gustafsson, M. Morgelin, and L. M. F. Leeb-Lundberg B1 Bradykinin Receptor Homo-Oligomers in Receptor Cell Surface Expression and Signaling: Effects of Receptor Fragments Mol. Pharmacol., January 1, 2005; 67(1): 309 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Rashid, B. F. O'Dowd, and S. R. George Minireview: Diversity and Complexity of Signaling through Peptidergic G Protein-Coupled Receptors Endocrinology, June 1, 2004; 145(6): 2645 - 2652. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Faussner, A. Bauer, I. Kalatskaya, M. Jochum, and H. Fritz Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Expression levels strongly affect ligand-induced sequestration of B2 bradykinin receptors in transfected cells Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1892 - H1898. [Abstract] [Full Text] [PDF] |
||||